Pages that link to "Q36781196"
Jump to navigation
Jump to search
The following pages link to Molecular profile of an antibody response to HIV-1 as probed by combinatorial libraries (Q36781196):
Displaying 50 items.
- Antibody vs. HIV in a clash of evolutionary titans (Q24536059) (← links)
- In vitro evolution of a neutralizing human antibody to human immunodeficiency virus type 1 to enhance affinity and broaden strain cross-reactivity (Q24563455) (← links)
- Polyclonal B cell responses to conserved neutralization epitopes in a subset of HIV-1-infected individuals (Q24635002) (← links)
- Hyperglycosylated Mutants of Human Immunodeficiency Virus (HIV) Type 1 Monomeric gp120 as Novel Antigens for HIV Vaccine Design (Q24679395) (← links)
- Oligonucleotide-assisted cleavage and ligation: a novel directional DNA cloning technology to capture cDNAs. Application in the construction of a human immune antibody phage-display library (Q24805914) (← links)
- A Blueprint for HIV Vaccine Discovery (Q26829865) (← links)
- Crystal structure of a 3B3 variantâ A broadly neutralizing HIV-1 scFv antibody (Q27657585) (← links)
- Structural Basis of Immune Evasion at the Site of CD4 Attachment on HIV-1 gp120 (Q27658449) (← links)
- Outer Domain of HIV-1 gp120: Antigenic Optimization, Structural Malleability, and Crystal Structure with Antibody VRC-PG04 (Q27675468) (← links)
- Biotechnological applications of phage and cell display (Q28208441) (← links)
- Fine mapping of the interaction of neutralizing and nonneutralizing monoclonal antibodies with the CD4 binding site of human immunodeficiency virus type 1 gp120. (Q28217208) (← links)
- Insensitivity of paediatric HIV-1 subtype C viruses to broadly neutralising monoclonal antibodies raised against subtype B (Q28469023) (← links)
- A directed molecular evolution approach to improved immunogenicity of the HIV-1 envelope glycoprotein (Q28743092) (← links)
- VH3 gene usage in neutralizing human antibodies specific for the Entamoeba histolytica Gal/GalNAc lectin heavy subunit (Q30452770) (← links)
- The rescue by phage display of human Fabs to gp120 HIV-1 glycoprotein using EBV transformed lymphocytes (Q30676629) (← links)
- Identification and characterization of a peptide that specifically binds the human, broadly neutralizing anti-human immunodeficiency virus type 1 antibody b12 (Q30701127) (← links)
- Cloning the antibody response in humans with inflammatory CNS disease: isolation of measles virus-specific antibodies from phage display libraries of a subacute sclerosing panencephalitis brain (Q30720487) (← links)
- Improving antibody affinity by mimicking somatic hypermutation in vitro (Q30724948) (← links)
- Molecular analysis of HIV-1 gp120 antibody response using isotype IgM and IgG phage display libraries from a long-term non-progressor HIV-1-infected individual (Q30784281) (← links)
- Generation of recombinant antibodies (Q30827091) (← links)
- Cloning the antibody response in humans with chronic inflammatory disease: immunopanning of subacute sclerosing panencephalitis (SSPE) brain sections with antibody phage libraries prepared from SSPE brain enriches for antibody recognizing measles vi (Q30831802) (← links)
- Creating and engineering human antibodies for immunotherapy (Q30874943) (← links)
- In vivo recombination as a tool to generate molecular diversity in phage antibody libraries (Q31005015) (← links)
- Broadly neutralizing antibodies targeted to the membrane-proximal external region of human immunodeficiency virus type 1 glycoprotein gp41. (Q31016954) (← links)
- Novel strategy for the selection of human recombinant Fab fragments to membrane proteins from a phage-display library (Q31039719) (← links)
- Anti-CD34+ Fabs generated against hematopoietic stem cells in HIV-derived combinatorial immunoglobulin library suggest antigen-selected autoantibodies (Q31937411) (← links)
- The maltose-binding protein as a scaffold for monovalent display of peptides derived from phage libraries (Q31994843) (← links)
- Selection of recombinant, library-derived antibody fragments against p24 for human immunodeficiency virus type 1 diagnostics. (Q32026627) (← links)
- Peptide and protein display on the surface of filamentous bacteriophage. (Q32039130) (← links)
- A phage display approach for rapid antibody humanization: designed combinatorial V gene libraries. (Q32052178) (← links)
- Antibody phage display technology and its applications. (Q32054935) (← links)
- Human antibodies with sub-nanomolar affinities isolated from a large non-immunized phage display library (Q32060783) (← links)
- Human antibody responses to mature and immature forms of viral envelope in respiratory syncytial virus infection: significance for subunit vaccines (Q33177627) (← links)
- Identification and characterization of a new cross-reactive human immunodeficiency virus type 1-neutralizing human monoclonal antibody (Q33205911) (← links)
- Rational monoclonal antibody development to emerging pathogens, biothreat agents and agents of foreign animal disease: The antigen scale (Q33222541) (← links)
- Generation, affinity maturation, and characterization of a human anti-human NKG2D monoclonal antibody with dual antagonistic and agonistic activity (Q33371167) (← links)
- HIV-1 gp41-specific monoclonal mucosal IgAs derived from highly exposed but IgG-seronegative individuals block HIV-1 epithelial transcytosis and neutralize CD4(+) cell infection: an IgA gene and functional analysis (Q33479955) (← links)
- Generation of a family-specific phage library of llama single chain antibody fragments that neutralize HIV-1 (Q33558279) (← links)
- Evaluation of CD4-CD4i antibody architectures yields potent, broadly cross-reactive anti-human immunodeficiency virus reagents (Q33558696) (← links)
- Effect of trimerization motifs on quaternary structure, antigenicity, and immunogenicity of a noncleavable HIV-1 gp140 envelope glycoprotein (Q33571825) (← links)
- Mining human antibody repertoires (Q33588489) (← links)
- Intracellular immunization of prokaryotic cells against a bacteriotoxin (Q33723619) (← links)
- Neutralization of human immunodeficiency virus type 1 by antibody to gp120 is determined primarily by occupancy of sites on the virion irrespective of epitope specificity (Q33782556) (← links)
- Human immunodeficiency virus type 1 attachment to HeLa CD4 cells is CD4 independent and gp120 dependent and requires cell surface heparans (Q33782608) (← links)
- Two N-linked glycosylation sites in the V2 and C2 regions of human immunodeficiency virus type 1 CRF01_AE envelope glycoprotein gp120 regulate viral neutralization susceptibility to the human monoclonal antibody specific for the CD4 binding domain (Q33826682) (← links)
- Antibody to gp41 MPER alters functional properties of HIV-1 Env without complete neutralization (Q33946158) (← links)
- Comparing antigenicity and immunogenicity of engineered gp120. (Q33984309) (← links)
- From catalytic asymmetric synthesis to the transcriptional regulation of genes: in vivo and in vitro evolution of proteins. (Q34070103) (← links)
- Molecular evolution of HIV-1 CRF01_AE Env in Thai patients (Q34071790) (← links)
- Anti-DNA antibodies are a major component of the intrathecal B cell response in multiple sclerosis (Q34105027) (← links)